Health Care: Drugs

Trinity Biotech PLC (TRIB: NASDAQ)

$16.0365 -0.0135 | -0.08%
10/24/14 - 10:22 AM ET
Company Profile
Price and Volume
Recent Price 16.05
52 Week High 28.06
52 Week Low 14.00
Avg. Daily Vol. (Mil) 0.12
Beta (3 year) 0.85
Share Related Items
Mkt Cap (Mil) 370.34
Shares Out (Mil) 23.07
Float (Mil) 0.00
Dividend Information
Yield % 1.40
Annual Dividend 0.22
Payout Ratio n.a.
Financial Strength
Quick Ratio 2.50
Current Ratio 4.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 3.68
Price/Book 1.89
Price/Cash Flow 27.20
Per Share Data
Earnings -0.19
Sales 4.36
Book Value 8.50
Cash Flow 0.59
Business Summary
Trinity Biotech PLC develops, acquires, manufactures & markets medical diagnostic products for clinical laboratory & point-of-care of diagnostic market. Its products are used to detect autoimmune, infectious, diabetes and disorders of liver & intestine.
General Information
IDA Business Park
Bray
Wicklow,
www.trinitybiotech.com
Industry : Drugs
Sector: Health Care
Employees: 571
CEO: Ronan O'Caoimh
Short Interest
Current Month (Mil) 0.44
Previous Month (Mil) 0.42
Short Interest Ratio (Days) 4.80
Management Effectiveness
Return on Equity 5.10
Return on Assets 4.20
Return on Investments 5.10
Profitability
Gross Margin 52.20
EBIT Margin 10.50
Profit Margin 10.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter